The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Journal club: SURMOUNT-OSA and a hard endpoint in a soft field

This is a generated summary. It shows the 7 most-liked posts from a topic of 52, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
C
CSagredoTL3Regular16 Feb 2025#1

Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that.

Collecting what is known about SURMOUNT-OSA in one place, because it is currently spread across a category, two tag pages and a thread that is hard to find.

This is a summary rather than new work, and I have attributed each part to where I found it.

45 likes 17mo
MN
m.ndiayeTL2 Solution20 Feb 2025#5

What I want from this SURMOUNT-OSA thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.

17 likes 17mo
B
BirkelandTL3Regular24 Feb 2025#10

Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.

If the premise is wrong, everything after it is decoration.

25 likes 17mo
RL
r.lundgrenTL228 Feb 2025 · edited#16

Taking post #13 at face value and following it one step further.

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

The confident version of this sentence would be wrong, so here is the hedged one.

25 likes 17mo
IL
integrator_logTL3Regular3 Mar 2025#21

Adding the measurement that post #18 says would settle it.

On SURMOUNT-OSA, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.

30 likes 17mo
JF
j.falkTL28 Mar 2025#30

Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything that follows.

Small point, but it is the one that usually catches people.

31 likes 17mo
KF
k.fonsecaTL29 Mar 2025#33

Coming back to post #31, because the follow-up matters more than the original answer.

The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.

That is all I can say without guessing.

27 likes 17mo

Read the full topic (52 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold?
The question in the title: Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? I will give what I have already checked below so nobody repeats it. Reading SUSTAIN 6 ( N Engl J Med ,…
RONSPPSDOB+60 66 12k 16mo
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Writing it up because I had to work it out twice and would rather nobody else did. The question about STEP 4 that I actually want…
AWFLAWCFZL+81 90 54k 9mo
Journal club: SELECT, absolute risk, and how it was reported
Journal club: SELECT, absolute risk, and how it was reported Writing it up because I had to work it out twice and would rather nobody else did. A question about what the numbers mean rather than what they…
MSFVJF 2 52k 1mo
Journal club: SELECT, absolute risk, and how it was reported — a second dataset
On the subject in the title: Journal club: SELECT, absolute risk, and how it was reported — a second dataset Working notes rather than a conclusion. Posting a small dataset on SELECT. It is mine, it is…
VKJBFNAITH 4 1.3k 1mo
Journal club: how we handle discontinuation in obesity trials
On the subject in the title: Journal club: how we handle discontinuation in obesity trials Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
LSCLPM 2 1.9k 12mo

Related topics — sharing the tags randomised trial, effect size, journal club

TopicParticipantsRepliesViewsActivity
Second pass at: Retatrutide mass and identity: what a report should show
Second pass at: Retatrutide mass and identity: what a report should show — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
CBTNNAFEKK+65 71 4.6k 13mo
Journal club: STEP 4 and what a withdrawal design can prove
On the subject in the title: Journal club: STEP 4 and what a withdrawal design can prove Working notes rather than a conclusion. Session topic: STEP 4 ( JAMA , 2021). Please read it before posting; the…
DJTVGHIO+61 65 2k 13mo
Semaglutide in people without diabetes: what the evidence base looks like
Semaglutide in people without diabetes: what the evidence base looks like Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of semaglutide…
GCSDNVMHN+2 6 18k 17mo
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like
On the subject in the title: Semaglutide in people without diabetes: what the evidence base looks like Working notes rather than a conclusion. Two things I would like separated before anyone answers on…
LPNMENALAT+41 46 1.2k 4mo
Journal club: STEP-HFpEF and symptom endpoints — a second dataset
On the subject in the title: Journal club: STEP-HFpEF and symptom endpoints — a second dataset Working notes rather than a conclusion. Posting a small dataset on step-hfpef and symptom endpoints. It is mine,…
EDCRFKTVIA+11 15 4k 10mo